Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Adenocarcinoma and CCL5[original query] |
|---|
| Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. Frontiers in oncology 2022 11 12 941868. Lao Yueqiong, Wang Yuqian, Yang Jie, Liu Tianyuan, Ma Yuling, Luo Yingying, Sun Yanxia, Li Kai, Zhao Xuan, Niu Xiangjie, Xi Yiyi, Zhong |
| Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy. Nature communications 2023 5 14 (1): 3155. Marjan M Naeini, Felicity Newell, Lauren G Aoude, Vanessa F Bonazzi, Kalpana Patel, Guy Lampe, Lambros T Koufariotis, Vanessa Lakis, Venkateswar Addala, Olga Kondrashova, Rebecca L Johnston, Sowmya Sharma, Sandra Brosda, Oliver Holmes, Conrad Leonard, Scott Wood, Qinying Xu, Janine Thomas, Euan Walpole, G Tao Mai, Stephen P Ackland, Jarad Martin, Matthew Burge, Robert Finch, Christos S Karapetis, Jenny Shannon, Louise Nott, Robert Bohmer, Kate Wilson, Elizabeth Barnes, John R Zalcberg, B Mark Smithers, John Simes, Timothy Price, Val Gebski, Katia Nones, David I Watson, John V Pearson, Andrew P Barbour, Nicola Wadde |
| Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma. Experimental & molecular medicine 2024 9 . Hyondeog Kim, Wonyeop Lee, Youngwook Kim, Sang-Jin Lee, Wonyoung Choi, Geon Kook Lee, Seung-Jin Park, Shinyeong Ju, Seon-Young Kim, Cheolju Lee, Ji-Youn H |
- Page last reviewed:Feb 1, 2024
- Content source: